VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Huntington Ingalls Industries, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Huntington Ingalls Industries, Inc.
HII · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Huntington Ingalls Industries, Inc.'s moat claims, evidence, and risks.
View HII analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Huntington Ingalls Industries, Inc. leads (83 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Huntington Ingalls Industries, Inc. has 3 segments (51.7% in Newport News Shipbuilding (Nuclear Shipbuilding)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Quasi-Monopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Huntington Ingalls Industries, Inc. has 6 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Huntington Ingalls Industries, Inc.
Newport News Shipbuilding (Nuclear Shipbuilding)
U.S. Navy nuclear shipbuilding and carrier lifecycle services (CVN construction/RCOH/inactivation + SSN/SSBN construction)
United States
U.S. Government (U.S. Navy)
Prime contractor shipyard / integrator
51.7%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Huntington Ingalls Industries, Inc. strengths
Sanofi strengths
Segment mix
Huntington Ingalls Industries, Inc. segments
Full profile >Newport News Shipbuilding (Nuclear Shipbuilding)
Quasi-Monopoly
Ingalls Shipbuilding (Non-Nuclear Shipbuilding)
Quasi-Monopoly
Mission Technologies (Defense Tech & Services)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.